Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Poston

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|May 9, 2006
Potentially inappropriate prescribing for elderly patients in 2 outpatient settingsVittorio Maio, Christine W Hartmann, Sara Poston, et al.
Human Vaccines & Immunotherapeutics|February 1, 2024
Respiratory syncytial virus knowledge, attitudes, and perceptions among adults in the United StatesElizabeth M La, Su Bunniran, Diana Garbinsky, et al.
Infectious Diseases and Therapy|October 11, 2025
Public Health Impact and Cost-Effectiveness of Adjuvanted RSVPreF3 Vaccination among Adults in the USA Aged 50-59 Years at Increased Risk of Severe RSV DiseaseDavid Singer, Elizabeth M La, Jonathan Graham, et al.
Human Vaccines & Immunotherapeutics|December 9, 2024
Cost-effectiveness of the adjuvanted RSVPreF3 vaccine among adults aged ≥60 years in the United StatesElizabeth M La, Jonathan Graham, David Singer, et al.
Infectious Diseases and Therapy|March 20, 2024
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United StatesDaniel Molnar, Elizabeth M La, Frederik Verelst, et al.
Vaccine|August 2, 2021
Cost-benefit analysis of vaccination against four preventable diseases in older adults: Impact of an aging populationJustin Carrico, Sandra E Talbird, Elizabeth M La, et al.
Human Vaccines & Immunotherapeutics|August 8, 2020
Impact of population aging on the burden of vaccine-preventable diseases among older adults in the United StatesSandra E Talbird, Elizabeth M La, Justin Carrico, et al.
Clinical Therapeutics|June 20, 2007
Topiramate prescribing patterns among medicaid patients: diagnosis, comorbidities, and dosingSara Poston, Michael Dickson, Michael Johnsrud, et al.
Health Affairs Scholar|November 25, 2024
Factors impacting vaccine uptake among adult Medicaid beneficiaries: a systematic literature reviewEmily Moss, Amanda L Eiden, Louise Hartley, et al.
P & T : a Peer-Reviewed Journal for Formulary Management|May 17, 2011
Impact of alvimopan (entereg) on hospital costs after bowel resection: results from a large inpatient databaseSara Poston, Michael S Broder, Melinda Maggard Gibbons, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|May 9, 2006
Potentially inappropriate prescribing for elderly patients in 2 outpatient settingsVittorio Maio, Christine W Hartmann, Sara Poston, et al.
Human Vaccines & Immunotherapeutics|February 1, 2024
Respiratory syncytial virus knowledge, attitudes, and perceptions among adults in the United StatesElizabeth M La, Su Bunniran, Diana Garbinsky, et al.
Infectious Diseases and Therapy|October 11, 2025
Public Health Impact and Cost-Effectiveness of Adjuvanted RSVPreF3 Vaccination among Adults in the USA Aged 50-59 Years at Increased Risk of Severe RSV DiseaseDavid Singer, Elizabeth M La, Jonathan Graham, et al.
Human Vaccines & Immunotherapeutics|December 9, 2024
Cost-effectiveness of the adjuvanted RSVPreF3 vaccine among adults aged ≥60 years in the United StatesElizabeth M La, Jonathan Graham, David Singer, et al.
Infectious Diseases and Therapy|March 20, 2024
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United StatesDaniel Molnar, Elizabeth M La, Frederik Verelst, et al.
Vaccine|August 2, 2021
Cost-benefit analysis of vaccination against four preventable diseases in older adults: Impact of an aging populationJustin Carrico, Sandra E Talbird, Elizabeth M La, et al.
Human Vaccines & Immunotherapeutics|August 8, 2020
Impact of population aging on the burden of vaccine-preventable diseases among older adults in the United StatesSandra E Talbird, Elizabeth M La, Justin Carrico, et al.
Clinical Therapeutics|June 20, 2007
Topiramate prescribing patterns among medicaid patients: diagnosis, comorbidities, and dosingSara Poston, Michael Dickson, Michael Johnsrud, et al.
Health Affairs Scholar|November 25, 2024
Factors impacting vaccine uptake among adult Medicaid beneficiaries: a systematic literature reviewEmily Moss, Amanda L Eiden, Louise Hartley, et al.
P & T : a Peer-Reviewed Journal for Formulary Management|May 17, 2011
Impact of alvimopan (entereg) on hospital costs after bowel resection: results from a large inpatient databaseSara Poston, Michael S Broder, Melinda Maggard Gibbons, et al.
Pageof 3